Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study

Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study

Background This phase 3 study evaluated the efficacy and safety of 6-month treatment with romosozumab in Korean postmenopausal women with osteoporosis. Methods Sixty-seven postmenopausal women with osteoporosis (bone mineral density [BMD] T-scores ≤−2.5 at the lumbar spine, total hip, or femoral nec...

Full description

Bibliographic Details
Main Authors: Ki-Hyun Baek, Yoon-Sok Chung, Jung-Min Koh, In Joo Kim, Kyoung Min Kim, Yong-Ki Min, Ki Deok Park, Rajani Dinavahi, Judy Maddox, Wenjing Yang, Sooa Kim, Sang Jin Lee, Hyungjin Cho, Sung-Kil Lim
Format: Article
Language:English
Published: Academya Publishing Co. 2021-02-01
Series:Endocrinology and Metabolism
Subjects:
bone density
bone turnover markers
korea
randomized controlled trial
romosozumab
Online Access:http://www.e-enm.org/upload/pdf/enm-2020-848.pdf

Internet

http://www.e-enm.org/upload/pdf/enm-2020-848.pdf

Similar Items